• BIO-key will hold its annual shareholder meeting in Holmdel, New Jersey on Sept. 3, 2026.
• Key vote targets authorization to issue up to 1,236,668 common shares tied to warrants from an Aug. 10, 2026 inducement transaction.
• Other items include electing five directors, auditor ratification for fiscal 2026, and an advisory vote on executive pay.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BIO-key International Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-028065), on August 14, 2026, and is solely responsible for the information contained therein.